ARS Pharmaceuticals, Inc. · BOATS:SPRY
ARS Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 184 institutions reported holding ARS Pharmaceuticals, Inc., 88.2% of its shares. Largest: Ra Capital Management, L.P., Rubric Capital Management LP and Orbimed Advisors LLC. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 10.9M | 10.8% | US$46.8M | No change | Nov 16, 2026 |
| Rubric Capital Management LP | 8.54M | 8.5% | US$36.8M | No change | Nov 16, 2026 |
| Orbimed Advisors LLC | 8.29M | 8.2% | US$35.7M | No change | Nov 16, 2026 |
| Deerfield Management Company, L.P. | 7.5M | 7.5% | US$32.3M | No change | Nov 16, 2026 |
| BlackRock | 5.58M | 5.6% | US$24.1M | +271K | Nov 13, 2026 |
| UBS | 4.13M | 4.1% | US$17.8M | +1.73M | Nov 16, 2026 |
| Sr One Capital Management, LP | 4.01M | 4.0% | US$17.3M | No change | Nov 16, 2026 |
| State Street | 3.69M | 3.7% | US$15.9M | −42,043 | Nov 12, 2026 |
| Vanguard | 3.6M | 3.6% | US$15.5M | −55,194 | Nov 13, 2026 |
| Millennium | 3.27M | 3.3% | US$14.1M | +869K | Nov 16, 2026 |
| Tyro Capital Management LLC | 3.2M | 3.2% | US$13.8M | −1.26M | Nov 12, 2026 |
| Capital Group | 1.96M | 2.0% | US$8.45M | −794K | Nov 12, 2026 |
| abrdn | 1.7M | 1.7% | US$7.33M | −2.47M | Nov 10, 2026 |
| Geode Capital | 1.6M | 1.6% | US$6.89M | −99,692 | Nov 6, 2026 |
| Janney Montgomery Scott LLC | 1.54M | 1.5% | US$6.65M | −522K | Nov 12, 2026 |
| Creek Drive Management Group LLC | 1.13M | 1.1% | US$4.85M | New | Nov 10, 2026 |
| Citadel | 1.08M | 1.1% | US$4.65M | +548K | Nov 16, 2026 |
| Third Point LLC | 1M | 0.99% | US$4.31M | No change | Nov 16, 2026 |
| General American Investors Co Inc | 908K | 0.90% | US$3.92M | −225K | Nov 2, 2026 |
| K2 Principal Fund, L.P. | 662K | 0.66% | US$2.85M | +287K | Nov 13, 2026 |
| Pavaki Capital Management LLC | 660K | 0.66% | US$2.84M | +80,000 | Oct 26, 2026 |
| Trexquant Investment LP | 600K | 0.60% | US$2.59M | +313K | Nov 16, 2026 |
| Tejara Capital Ltd | 589K | 0.59% | US$2.54M | −17,997 | Nov 9, 2026 |
| ADAR1 Capital Management, LLC | 561K | 0.56% | US$2.42M | −40,000 | Nov 16, 2026 |
| Northern Trust | 545K | 0.54% | US$2.35M | −3,613 | Nov 16, 2026 |
| Landscape Capital Management, L.L.C. | 483K | 0.48% | US$2.08M | New | Nov 10, 2026 |
| Schwab | 478K | 0.48% | US$2.06M | −73,542 | Nov 16, 2026 |
| Empire Life Investments Inc. | 469K | 0.47% | US$2.02M | −2,697 | Nov 6, 2026 |
| FIL Ltd | 456K | 0.45% | US$1.96M | No change | Nov 10, 2026 |
| Marshall Wace, LLP | 450K | 0.45% | US$1.94M | +326K | Nov 13, 2026 |
| Eversept Partners, LP | 449K | 0.45% | US$1.94M | +72,158 | Nov 16, 2026 |
| CenterBook Partners LP | 419K | 0.42% | US$1.81M | +296K | Nov 2, 2026 |
| Investment Management Associates Inc | 393K | 0.39% | US$1.7M | +19,937 | Oct 29, 2026 |
| Morgan Stanley | 375K | 0.37% | US$1.61M | +146K | Nov 13, 2026 |
| Levin Capital Strategies, L.P. | 369K | 0.37% | US$1.59M | −179K | Nov 2, 2026 |
| Raymond James Financial Inc | 365K | 0.36% | US$1.57M | +46,714 | Nov 12, 2026 |
| Goldman Sachs | 325K | 0.32% | US$1.4M | −56,089 | Nov 16, 2026 |
| Bank of America | 300K | 0.30% | US$1.29M | −163K | Nov 16, 2026 |
| Hennion & Walsh Asset Management, Inc. | 252K | 0.25% | US$1.09M | +76,863 | Oct 13, 2026 |
| FAS Wealth Partners, Inc. | 244K | 0.24% | US$1.05M | +29,825 | Nov 16, 2026 |
| Quantinno Capital Management LP | 221K | 0.22% | US$953K | +96,687 | Nov 13, 2026 |
| Nuveen | 203K | 0.20% | US$874K | +41,422 | Nov 10, 2026 |
| Ishara Investments LP | 200K | 0.20% | US$862K | +56,510 | Nov 16, 2026 |
| DAFNA Capital Management LLC | 183K | 0.18% | US$788K | +18,500 | Nov 16, 2026 |
| Quinn Opportunity Partners LLC | 175K | 0.17% | US$754K | No change | Nov 10, 2026 |
| Renaissance Technologies | 174K | 0.17% | US$751K | New | Nov 12, 2026 |
| BNY | 170K | 0.17% | US$732K | +1,620 | Nov 5, 2026 |
| Balyasny Asset Management L.P. | 164K | 0.16% | US$708K | +99,583 | Nov 16, 2026 |
| State Of Wisconsin Investment Board | 127K | 0.13% | US$546K | +113K | Nov 16, 2026 |
| Barclays | 125K | 0.12% | US$540K | −923 | Nov 6, 2026 |
This page holds 50 of 184 holders.
Funds
| Holder | Shares | Of the company | Value | Change | As of |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | 2.68M | 2.7% | US$21.5M | New | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 2.29M | 2.3% | US$18.3M | +73,535 | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1.75M | 1.7% | US$14M | No change | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1.61M | 1.6% | US$12.9M | +159K | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 746K | 0.74% | US$5.98M | +11,746 | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 670K | 0.67% | US$3.44M | +86,634 | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 578K | 0.58% | US$4.63M | +101K | Jun 30, 2026 |
| iShares Biotechnology ETF | 442K | 0.44% | US$3.54M | −21,289 | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 339K | 0.34% | US$3.08M | −4,411 | May 31, 2026 |
| Select Biotechnology Portfolio | 335K | 0.33% | US$3.04M | No change | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 311K | 0.31% | US$2.82M | −5,014 | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 304K | 0.30% | US$2.75M | +10,996 | May 31, 2026 |
| Optimum Small-Mid Cap Growth Fund | 220K | 0.22% | US$1.76M | New | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 162K | 0.16% | US$1.47M | −1,379 | May 31, 2026 |
| Schwab Small-Cap Index Fund | 150K | 0.15% | US$769K | +22,959 | Jul 31, 2026 |
| JPMorgan U.S. Small Company Fund | 126K | 0.13% | US$1.01M | −9,134 | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 125K | 0.12% | US$1.13M | No change | May 31, 2026 |
| Master Small Cap Index Series | 117K | 0.12% | US$938K | +22,519 | Jun 30, 2026 |
| Empower Small Cap Growth Fund | 110K | 0.11% | US$877K | New | Jun 30, 2026 |
| ALPS Medical Breakthroughs ETF | 102K | 0.10% | US$928K | +14,252 | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 99,474 | 0.10% | US$902K | +4,860 | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 81,812 | 0.08% | US$420K | +10,646 | Jul 31, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 81,043 | 0.08% | US$649K | +1,904 | Jun 30, 2026 |
| Direxion Daily S&P Biotech Bull 3X Shares | 77,714 | 0.08% | US$399K | −48,902 | Jul 31, 2026 |
| Sit Small Cap Growth Fund | 73,100 | 0.07% | US$586K | No change | Jun 30, 2026 |
| SMALLCAP World Fund | 72,743 | 0.07% | US$583K | New | Jun 30, 2026 |
| EQ/2000 Managed Volatility Portfolio | 66,999 | 0.07% | US$537K | +3,129 | Jun 30, 2026 |
| Nuveen Equity Index Fund | 64,997 | 0.06% | US$333K | No change | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 59,377 | 0.06% | US$539K | +2,601 | May 31, 2026 |
| Fidelity Small Cap Growth Index Fund | 57,726 | 0.06% | US$462K | +12,890 | Jun 30, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 55,257 | 0.05% | US$501K | +963 | May 31, 2026 |
| Royce Smaller-Companies Growth Fund | 54,000 | 0.05% | US$433K | No change | Jun 30, 2026 |
| iShares U.S. Small-Cap Equity Factor ETF | 51,192 | 0.05% | US$263K | −118K | Jul 31, 2026 |
| Schwab U.S. Broad Market ETF | 48,109 | 0.05% | US$436K | +479 | May 31, 2026 |
| Schwab Total Stock Market Index Fund | 41,900 | 0.04% | US$215K | No change | Jul 31, 2026 |
| LVIP State Street Small-Cap Index Fund | 40,200 | 0.04% | US$322K | No change | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index ETF | 40,147 | 0.04% | US$364K | −491 | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 39,569 | 0.04% | US$203K | −43,820 | Jul 31, 2026 |
| Fidelity ZERO Total Market Index Fund | 34,828 | 0.03% | US$179K | +1,931 | Jul 31, 2026 |
| Small Cap Index Fund | 31,857 | 0.03% | US$255K | +5,981 | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 30,213 | 0.03% | US$242K | No change | Jun 30, 2026 |
| Global X Russell 2000 ETF | 29,426 | 0.03% | US$151K | +3,800 | Jul 31, 2026 |
| LVIP JPMorgan Small Cap Core Fund | 28,221 | 0.03% | US$226K | −1,595 | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 27,743 | 0.03% | US$222K | No change | Jun 30, 2026 |
| EQ/Small Company Index Portfolio | 27,230 | 0.03% | US$218K | No change | Jun 30, 2026 |
| Fidelity ZERO Extended Market Index Fund | 25,248 | 0.03% | US$130K | +2,224 | Jul 31, 2026 |
| Small Cap Index Fund | 22,463 | 0.02% | US$204K | −460 | May 31, 2026 |
| Fidelity MSCI Health Care Index ETF | 22,392 | 0.02% | US$115K | −2,525 | Jul 31, 2026 |
| EQ/AB Small Cap Growth Portfolio | 22,120 | 0.02% | US$177K | +17,510 | Jun 30, 2026 |
| Biotechnology Ultrasector Profund | 21,806 | 0.02% | US$112K | −17,379 | Jul 31, 2026 |
This page holds 50 of 127 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| Ra Capital Management, L.P. | 11.10% | 10.9M | Sep 29, 2025 |
| Rubric Capital Management LP | 8.06% | 8M | Mar 31, 2026 |
| Deerfield Management Company, L.P. | 7.75% | 7.61M | Jul 30, 2025 |
| BlackRock, Inc. | 5.30% | 5.22M | Jun 30, 2026 |